LP
BBNX

Longaeva Partners’s Beta Bionics BBNX Stock Holding History

Longaeva Partners’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-125,483
Closed -$2.49M – 153
2025
Q3 		$2.49M Sell
125,483
-71,124
-36% -$1.25M 0.36% 46
2025
Q2 		$2.86M Sell
196,607
-79,218
-29% -$1.12M 0.58% 29
2025
Q1 		$3.38M Buy
+275,825
New +$5.14M 1.91% 12

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Longaeva Partners's BBNX Position: Q4 2025 in Review

Longaeva Partners sold out of Beta Bionics (BBNX) in Q4 2025, closing a stake of 125,483 shares — an estimated $2.49M sold.

Longaeva Partners first reported a position in BBNX in Q1 2025 and held it in 3 quarters. The position peaked at $3.38M in Q1 2025. 158 funds tracked by Wall St. Rank hold BBNX as of Q4 2025.

  • Longaeva Partners reported no remaining Beta Bionics position as of Q4 2025 after selling out during the quarter.
  • Longaeva Partners sold 125,483 Beta Bionics shares in Q4 2025, an estimated $2.49M.
  • Longaeva Partners first reported a position in Beta Bionics in Q1 2025 and held it in 3 quarters.
  • Longaeva Partners's Beta Bionics position peaked at $3.38M in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Beta Bionics as of Q4 2025.

Based on Longaeva Partners's 13F filing for Q4 2025, filed 17 Feb 2026.